Search results for:
asparaginase Erwinia chrysanthemi, recombinant
asparaginase Erwinia chrysanthemi, recombinant
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Rylaze |
SOLUTION, INTRAMUSCULAR |
10 mg/0.5 mL |
|
|
|
|
Last updated: Nov. 30, 2022
- Formulary, Not Routinely Stocked:
Rylaze should only be used in patients who have a demonstrated hypersensitivity reaction to E. coli derived asparaginase products.
Reviewed: Nov. 2022 (Rylaze)